Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244174.RANsWPdszqAOQ-O3C86fRaWZuXqm-S8Cz7YoH3S5XTBCQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244174.RANsWPdszqAOQ-O3C86fRaWZuXqm-S8Cz7YoH3S5XTBCQ130_assertion type Assertion NP1244174.RANsWPdszqAOQ-O3C86fRaWZuXqm-S8Cz7YoH3S5XTBCQ130_head.
- NP1244174.RANsWPdszqAOQ-O3C86fRaWZuXqm-S8Cz7YoH3S5XTBCQ130_assertion description "[Adverse events reported in more than 10% of patients were fatigue (66 patients, 26% [95% CI 21-32]), headache (58 patients, 23% [95% CI 18-29]), and asthenia (35 patients, 14% [95% CI 10-19]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244174.RANsWPdszqAOQ-O3C86fRaWZuXqm-S8Cz7YoH3S5XTBCQ130_provenance.
- NP1244174.RANsWPdszqAOQ-O3C86fRaWZuXqm-S8Cz7YoH3S5XTBCQ130_assertion evidence source_evidence_literature NP1244174.RANsWPdszqAOQ-O3C86fRaWZuXqm-S8Cz7YoH3S5XTBCQ130_provenance.
- NP1244174.RANsWPdszqAOQ-O3C86fRaWZuXqm-S8Cz7YoH3S5XTBCQ130_assertion SIO_000772 25467591 NP1244174.RANsWPdszqAOQ-O3C86fRaWZuXqm-S8Cz7YoH3S5XTBCQ130_provenance.
- NP1244174.RANsWPdszqAOQ-O3C86fRaWZuXqm-S8Cz7YoH3S5XTBCQ130_assertion wasDerivedFrom befree-2016 NP1244174.RANsWPdszqAOQ-O3C86fRaWZuXqm-S8Cz7YoH3S5XTBCQ130_provenance.
- NP1244174.RANsWPdszqAOQ-O3C86fRaWZuXqm-S8Cz7YoH3S5XTBCQ130_assertion wasGeneratedBy ECO_0000203 NP1244174.RANsWPdszqAOQ-O3C86fRaWZuXqm-S8Cz7YoH3S5XTBCQ130_provenance.